Liquid biopsy companies develop minimally invasive tests that analyse tumour-derived and other disease-associated material found in blood or bodily fluids. These technologies support earlier detection, treatment selection, response monitoring and the identification of disease recurrence.
This category includes companies working on:
Browse 34 UK liquid biopsy companies below.
Organ-specific liquid biopsy tests for early cancer detection
Mursla Bio is a diagnostics company developing blood-based tests for early cancer detection using extracellular vesicle biology. Its platform isolates organ-specific extracellular…
Multiomics platform for cancer biomarker discovery and diagnostics
Tagomics is a Cambridge-based biotech developing a multiomics platform for disease biomarker discovery and diagnostics. Its platform integrates genomics, epigenomics and…
Chromatography columns and sample preparation products for analytical science
Phenomenex is a global manufacturer and supplier of analytical chemistry consumables and instruments, specialising in chromatography columns and sample preparation products for…
Molecular diagnostic kits and genomic services for clinical laboratories
Yourgene Health is a molecular diagnostics company developing, manufacturing and commercialising IVD reagent kits and genomic services for reproductive health, precision medicine…
Astrophysics-derived AI platform predicting cancer treatment response
Concr is a London-based precision oncology company that applies Bayesian AI adapted from astrophysics to predict individual cancer treatment responses. Its platform integrates…
Preimplantation and prenatal genetic testing for reproductive medicine
Juno Genetics is a specialist reproductive genetics laboratory providing preimplantation genetic testing (PGT) services to IVF clinics in the UK and internationally. Using its…
Real-world clinical data platform for life science research
Arcturis is a real-world data and evidence company that aggregates longitudinal, secondary-care patient records from a network of NHS hospitals into research-ready,…
Molecular diagnostic assay development for oncology biomarkers
APIS Assay Technologies is a molecular diagnostics company developing and commercialising genomic assays for oncology and personalised medicine. The company combines an in-house…
Multiomics blood-based platform for early-stage cancer detection
Freenome is a biotechnology company developing blood-based early cancer detection tests using a multiomics platform that combines tumour and non-tumour biological signals with…
Enzyme-free multiplex RNA diagnostics for rapid clinical decisions
Cambridge Nucleomics is a biotechnology company developing a proprietary nanopore-based platform for rapid, high-multiplexed detection of nucleic acid biomarkers. Its enzyme-free…